Prime Time for HLA Desensitization: Imlifidase in the Spotlight

Transpl Int. 2023 Jun 28:36:11616. doi: 10.3389/ti.2023.11616. eCollection 2023.

Authors

Oriol Bestard¹, Francesc Moreso¹, Anthony Dorling²

Affiliations

¹ Kidney Transplant Unit, Nephrology Department, Vall d'Hebron University Hospital, Barcelona, Spain.
² Centre for Nephrology, Urology and Transplantation, King's College London, London, United Kingdom.

No abstract available

Keywords: HLA allosensitization; desensitization; rejection; survival benefit; transplant access.

Publication types

Comment

MeSH terms

Humans
Immunosuppressive Agents
Isoantibodies
Kidney Transplantation*

Substances

Immunosuppressive Agents
Isoantibodies

Grants and funding

MR/T025573/1/MRC_/Medical Research Council/United Kingdom